vs

Side-by-side financial comparison of BNY Mellon (BK) and Emerson Electric (EMR). Click either name above to swap in a different company.

BNY Mellon is the larger business by last-quarter revenue ($5.4B vs $4.6B, roughly 1.2× Emerson Electric). BNY Mellon runs the higher net margin — 30.1% vs 13.5%, a 16.6% gap on every dollar of revenue. On growth, BNY Mellon posted the faster year-over-year revenue change (12.9% vs 3.0%). Over the past eight quarters, BNY Mellon's revenue compounded faster (129.2% CAGR vs -0.6%).

The Bank of New York Mellon Corporation, commonly known as BNY or by its prior brand name BNY Mellon, is an American international financial services company headquartered in New York City. It was established in its current form in July 2007 by the merger of the Bank of New York and Mellon Financial Corporation.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

BK vs EMR — Head-to-Head

Bigger by revenue
BK
BK
1.2× larger
BK
$5.4B
$4.6B
EMR
Growing faster (revenue YoY)
BK
BK
+9.9% gap
BK
12.9%
3.0%
EMR
Higher net margin
BK
BK
16.6% more per $
BK
30.1%
13.5%
EMR
Faster 2-yr revenue CAGR
BK
BK
Annualised
BK
129.2%
-0.6%
EMR

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
BK
BK
EMR
EMR
Revenue
$5.4B
$4.6B
Net Profit
$1.6B
$618.0M
Gross Margin
53.1%
Operating Margin
Net Margin
30.1%
13.5%
Revenue YoY
12.9%
3.0%
Net Profit YoY
33.4%
43.7%
EPS (diluted)
$2.24
$1.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BK
BK
EMR
EMR
Q2 26
$4.6B
Q1 26
$5.4B
$4.3B
Q4 25
$1.3B
$4.3B
Q3 25
$1.2B
$4.9B
Q2 25
$1.2B
$4.6B
Q1 25
$1.2B
$4.4B
Q4 24
$1.2B
$4.2B
Q3 24
$1.0B
$4.6B
Net Profit
BK
BK
EMR
EMR
Q2 26
$618.0M
Q1 26
$1.6B
$606.0M
Q4 25
$1.5B
$605.0M
Q3 25
$1.4B
$637.0M
Q2 25
$1.4B
$586.0M
Q1 25
$1.2B
$485.0M
Q4 24
$1.2B
$585.0M
Q3 24
$1.2B
$996.0M
Gross Margin
BK
BK
EMR
EMR
Q2 26
53.1%
Q1 26
53.2%
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Operating Margin
BK
BK
EMR
EMR
Q2 26
Q1 26
Q4 25
17.8%
Q3 25
16.4%
Q2 25
16.1%
Q1 25
14.2%
Q4 24
18.6%
Q3 24
14.7%
Net Margin
BK
BK
EMR
EMR
Q2 26
13.5%
Q1 26
30.1%
13.9%
Q4 25
108.5%
13.9%
Q3 25
116.9%
13.1%
Q2 25
118.3%
12.9%
Q1 25
105.3%
10.9%
Q4 24
96.7%
14.0%
Q3 24
112.8%
21.6%
EPS (diluted)
BK
BK
EMR
EMR
Q2 26
$1.10
Q1 26
$2.24
$1.07
Q4 25
$2.01
$1.07
Q3 25
$1.88
$1.12
Q2 25
$1.93
$1.04
Q1 25
$1.58
$0.86
Q4 24
$1.53
$1.02
Q3 24
$1.50
$1.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BK
BK
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$1.8B
Total DebtLower is stronger
$32.6B
$13.4B
Stockholders' EquityBook value
$172.0B
$20.3B
Total Assets
$561.5B
$42.1B
Debt / EquityLower = less leverage
0.19×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BK
BK
EMR
EMR
Q2 26
$1.8B
Q1 26
$1.7B
Q4 25
$5.1B
Q3 25
$5.1B
Q2 25
$5.7B
Q1 25
$5.4B
Q4 24
$4.2B
Q3 24
$6.2B
Total Debt
BK
BK
EMR
EMR
Q2 26
$13.4B
Q1 26
$32.6B
$13.4B
Q4 25
$31.9B
$7.6B
Q3 25
$32.3B
$8.9B
Q2 25
$33.4B
$8.3B
Q1 25
$30.9B
$8.2B
Q4 24
$30.9B
$6.6B
Q3 24
$33.2B
$7.7B
Stockholders' Equity
BK
BK
EMR
EMR
Q2 26
$20.3B
Q1 26
$172.0B
$20.3B
Q4 25
$44.3B
$20.3B
Q3 25
$43.9B
$20.3B
Q2 25
$44.0B
$19.9B
Q1 25
$43.1B
$19.2B
Q4 24
$41.3B
$20.5B
Q3 24
$42.0B
$21.6B
Total Assets
BK
BK
EMR
EMR
Q2 26
$42.1B
Q1 26
$561.5B
$41.9B
Q4 25
$472.3B
$41.9B
Q3 25
$455.3B
$42.0B
Q2 25
$485.8B
$42.5B
Q1 25
$440.7B
$42.0B
Q4 24
$416.1B
$42.6B
Q3 24
$427.5B
$44.2B
Debt / Equity
BK
BK
EMR
EMR
Q2 26
0.66×
Q1 26
0.19×
0.66×
Q4 25
0.72×
0.37×
Q3 25
0.74×
0.44×
Q2 25
0.76×
0.42×
Q1 25
0.72×
0.42×
Q4 24
0.75×
0.32×
Q3 24
0.79×
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BK
BK
EMR
EMR
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$694.0M
FCF MarginFCF / Revenue
15.2%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BK
BK
EMR
EMR
Q2 26
Q1 26
Q4 25
$5.2B
$699.0M
Q3 25
$-1.1B
$3.1B
Q2 25
$2.2B
$1.1B
Q1 25
$412.0M
$241.0M
Q4 24
$1.6B
$777.0M
Q3 24
$-312.0M
$3.3B
Free Cash Flow
BK
BK
EMR
EMR
Q2 26
$694.0M
Q1 26
$602.0M
Q4 25
$4.7B
$602.0M
Q3 25
$-1.5B
$2.7B
Q2 25
$1.8B
$977.0M
Q1 25
$92.0M
$154.0M
Q4 24
$1.1B
$694.0M
Q3 24
$-687.0M
$2.9B
FCF Margin
BK
BK
EMR
EMR
Q2 26
15.2%
Q1 26
13.9%
Q4 25
352.8%
13.9%
Q3 25
-121.5%
54.9%
Q2 25
152.8%
21.5%
Q1 25
7.9%
3.5%
Q4 24
95.2%
16.6%
Q3 24
-65.6%
63.1%
Capex Intensity
BK
BK
EMR
EMR
Q2 26
4.0%
Q1 26
2.2%
Q4 25
32.4%
2.2%
Q3 25
35.4%
8.9%
Q2 25
29.8%
2.0%
Q1 25
27.6%
2.0%
Q4 24
34.6%
2.0%
Q3 24
35.8%
9.1%
Cash Conversion
BK
BK
EMR
EMR
Q2 26
Q1 26
Q4 25
3.55×
1.16×
Q3 25
-0.74×
4.86×
Q2 25
1.54×
1.83×
Q1 25
0.34×
0.50×
Q4 24
1.34×
1.33×
Q3 24
-0.26×
3.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BK
BK

Investment services fees$2.7B49%
Other$1.4B25%
Investment management and performance fees$785.0M15%
Investment and other revenue$271.0M5%
Foreign exchange revenue$232.0M4%
Financing-related fees$62.0M1%
Distribution and servicing fees$37.0M1%

EMR
EMR

Segment breakdown not available.

Related Comparisons